Skip to content

Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q2Scopus Q1
Journal
CANCERS15(5) · 2023
Citation
Web of Science 4Scopus 5
FWCI (Scopus)
0.4
JCR IF
JCR 2022 5.2
ISSN
2072-6694

Authors

  1. Kim, InsuFirst authorDong A Univ Hosp, Dept Internal Med, Busan 49201, South Korea
  2. Seol, Hee YunPusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan 50612, South Korea
  3. Kim, SooHanPusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
  4. Kim, Mi-HyunPusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
  5. Lee, Min KiPusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
  6. Eom, Jung SeopCorresponding authorPusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea

Abstract

Background: Detection of the epidermal growth factor receptor (EGFR) T790M mutation using plasma samples has been considered simple and non-invasive, but the relatively high false negative results lead to additional tissue sampling in some patients. Until now, the characteristics of patients who prefer liquid biopsy have not yet been established. Methods: To evaluate the favorable conditions for the detection of T790M mutations using plasma samples, a multicenter retrospective study was performed between May 2018 and December 2021. Patients whose T790M mutation was detected in a plasma sample were classified as the plasma positive group. Study subjects with a T790M mutation not detected in a plasma sample but only in a tissue sample were grouped as the plasma false negative group. Results: Plasma positive and plasma false negative groups were found in 74 and 32 patients, respectively. As a result, 40% of patients with one or two metastatic organs at the time of re-biopsy had false negative plasma sample results, and 69% of patients with three or more metastatic organs at the time of re-biopsy had positive plasma results. In multivariate analysis, three or more metastatic organs at initial diagnosis were independently associated with the detection of a T790M mutation using plasma samples. Conclusion: Our results demonstrated that the detection rate of a T790M mutation using plasma samples was related to the tumor burden, particularly to the number of metastatic organs.

Keywords

diagnostic molecular pathologyepidermal growth factor receptorliquid biopsylung cancertyrosine kinase inhibitorLIQUID-BIOPSYRESISTANCEGUIDELINE

Identifiers

Scopus EID
2-s2.0-85149806494
WoS UID
000947421400001